We’re supporting clients through every stage of their brand and product lifecycle.
Our centers of expertise span therapeutic areas, markets and geographies, and are underpinned by these four core research principles:
Mobile navigation menu modal
Our client was in the process of beginning a pivotal trial for a new anti-sense therapy designed to specifically bind to the mRNA.
In April 2019, Brazilian Health Minister Luiz Henrique Mandetta announced a pilot agreement for access to Biogen’s spinal muscular atrophy (SMA).
Rapport is our monthly newsletter where we share our latest expertise and experience.
